| Literature DB >> 27487931 |
Tobias Bock1, Rolf Müller2, Wulf Blankenfeldt1.
Abstract
Isovaleryl coenzyme A (IV-CoA) performs a crucial role during development and fruiting-body formation in myxobacteria, which is reflected in the existence of a de novo biosynthetic pathway that is highly upregulated when leucine, the common precursor of IV-CoA, is limited. The final step in de novo IV-CoA biosynthesis is catalyzed by AibC, a medium-chain dehydrogenase/reductase. Here, the crystal structure of AibC from Myxococcus xanthus refined to 2.55 Å resolution is presented. The protein adopts two different conformations in the crystal lattice, which is a consequence of partial interaction with the purification tag. Based on this structure, it is suggested that AibC most probably uses a Zn(2+)-supported catalytic mechanism in which NADPH is preferred over NADH. Taken together, this study reveals structural details of the alternative IV-CoA-producing pathway in myxobacteria, which may serve as a base for further biotechnological research and biofuel production.Entities:
Keywords: Myxococcus xanthus; TEV protease-recognition sequence; alternative isovaleryl coenzyme A biosynthesis; hexahistidine tag; medium-chain dehydrogenase/reductase; zinc-dependence
Mesh:
Substances:
Year: 2016 PMID: 27487931 PMCID: PMC4973308 DOI: 10.1107/S2053230X16011146
Source DB: PubMed Journal: Acta Crystallogr F Struct Biol Commun ISSN: 2053-230X Impact factor: 1.056